A Perfect MASH Comparing Resmetirom and GLP-1 Agonists for Metabolic-Associated Steatohepatitis: What Does the Current Evidence Suggest?
1. 系统已在2026-03-16 16:23:53对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
J Lin, V Green, A Sohal, M Roytman
Journal of Clinical …, 2025
journals.lww.com
… as HSD17B13 have been noted to be protective against MASH, and current studies are
aiming to alter gene expression related to liver-specific MASH progression, 79 while GLP-1 RAs …

